1,1'-(对苯基二亚甲基)双[3-(2-羟基乙基)]脲 | 7747-61-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1,1'-(对苯基二亚甲基)双[3-(2-羟基乙基)]脲
• 英文名称: 1,1-(methanediyldibenzene-4,1-diyl)bis[3-(2-hydroxyethyl)urea]
• 英文别名: Cambridge id 5578963；1-(2-hydroxyethyl)-3-[4-[[4-(2-hydroxyethylcarbamoylamino)phenyl]methyl]phenyl]urea
• CAS: 7747-61-7
• 化学式: C₁₉H₂₄N₄O₄
• 分子量: 372.424
• InChiKey: LZUBGQYVUZIPHB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.26
• 拓扑面积：
  123
• 氢给体数：
  6
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  C.I.酸性橙108 、 4,4'-二苯甲烷二异氰酸酯、2,4'-二苯甲烷二异氰酸酯和2,2'-二苯甲烷二异氰酸酯的混合物 以 氯仿 为溶剂， 生成 1,1'-(对苯基二亚甲基)双[3-(2-羟基乙基)]脲
  参考文献：
  名称：

  Arkhireev,V.P. et al., Journal of Organic Chemistry USSR (English Translation), 1970, vol. 6, p. 2042 - 2043

  摘要：

  DOI：

文献信息

• Base-stabilized polyorthoester formulations
  申请人：Shah T. Devang

  公开号：US20070264338A1

  公开（公告）日：2007-11-15

  A stabilized semi-solid delivery vehicle contains a polyorthoester and an excipient, and a pharmaceutical composition contains an active agent, optionally a stabilizing agent, and the delivery vehicle. The pharmaceutical composition may be a topical, syringable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

  一种稳定的半固态给药载体包含聚正交酯和辅料，以及一种药物组合物包含活性药剂，可选地包含稳定剂和给药载体。该药物组合物可以是局部、可注射或可注射的配方；适用于活性药剂的局部给药。还公开了治疗方法。
• PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
  申请人：——

  公开号：US20030152630A1

  公开（公告）日：2003-08-14

  PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers have both hydrophilic and hydrophobic blocks. They form micelles in aqueous solution, making them suitable for encapsulation or solubilization of hydrophobic or water-insoluble materials; and they also form bioerodible matrices for the sustained release of active agents, especially when the POE block(s) contain at least one unit containing an &agr;-hydroxy acid.

  PEG-POE，PEG-POE-PEG和POE-PEG-POE嵌段共聚物具有亲水和疏水区块。它们在水溶液中形成胶束，适用于包封或溶解疏水或不溶于水的材料；它们还形成可生物降解的基质，用于持续释放活性剂，特别是当POE区块中至少含有一个含有α-羟基酸的单元时。
• PROCESSES FOR PRODUCING ARYL CARBAMATES, ISOCYNATES AND POLYUREAS USING DIARYL CARBONATE
  申请人：Dai Shenghong A.

  公开号：US20130079542A1

  公开（公告）日：2013-03-28

  A preparation of aryl carbamates can be achieved readily by carbonylation of an aromatic polyamine compound with diphenyl carbonate (DPC) using a combination of an organic acid and a tertiary amine as a catalyst. Aryl carbamate can be converted into 4,4′-diphenylmethane diisocyanate (MDI) by heating it at about 200 to about 230° C. in a non-polar solvent containing inhibitor such as benzoyl chloride. In another application, trans-ureation of biscarbamates with an amine or mixed amines is found to be extremely facile in a polar solvent such as dimethyl sulfoxide (DMSO) and tetramethylene sulfone (TMS) in absence of any catalyst to make polyurea polymers of high molecular weights. Thus, efficient green-chemistry processes based on biscarbamates in making isocyanate products as well as urea prepolymers, urea elastomers and urea plastics have been developed in all in excellent yields without using reactive phosgene or 4,4′-diphenylmethane diisocyanate separately in the trans-ureation polymerizations.

  芳基氨基甲酸酯的制备可通过芳香族多胺化合物与二苯基碳酸酯（DPC）在有机酸和三级胺的催化剂作用下进行羰基化而轻松实现。将芳基氨基甲酸酯加热至约200至230°C，在含有苯甲酰氯等抑制剂的非极性溶剂中，可将其转化为4,4′-二苯甲烷二异氰酸酯（MDI）。在另一个应用中，使用极性溶剂如二甲基亚砜（DMSO）和四甲基砜（TMS）中，通过与胺或混合胺进行双氨基甲酸酯的转尿素化，在无催化剂的情况下制备高分子量的聚脲聚合物是非常容易的。因此，基于双氨基甲酸酯的高效绿色化学过程已经开发出以优异产率制备异氰酸酯产品、尿素预聚合物、尿素弹性体和尿素塑料的方法，而无需在转尿素聚合过程中单独使用反应性的光气或4,4′-二苯甲烷二异氰酸酯。
• Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
  申请人：——

  公开号：US20040096506A1

  公开（公告）日：2004-05-20

  Bioerodible poly(ortho esters) useful as orthopedic implants or vehicles for the sustained delivery of pharmaceutical, cosmetic and agricultural agents from dioxane-based di(ketene acetals). Block copolymers contain these bioerodible poly(ortho esters). These block copolymers have both hydrophilic and hydrophobic blocks. They form micelles in aqueous solution, making them suitable for encapsulation or solubilization of hydrophobic or water-insoluble materials; and they also form bioerodible matrices for the sustained release of active agents.

  生物可降解的聚酯类（ortho esters）可用作骨科植入物或从二噁烷基二（酮酸酯）中提供药物、化妆品和农业剂量的持续释放载体。这些生物可降解的聚酯类是由含有这些聚酯类的嵌段共聚物组成的。这些嵌段共聚物具有亲水和疏水的嵌段。它们在水溶液中形成胶束，适用于封装或溶解疏水或不溶于水的材料；它们还形成生物可降解的基质，用于持续释放活性成分。
• Semi-solid delivery vehicle and pharmaceutical compositions
  申请人：Heron Therapeutics, Inc.

  公开号：EP2902012A1

  公开（公告）日：2015-08-05

  A semi-solid delivery vehicle contains a polyorthoester and an excipient, and a semi-solid pharmaceutical composition contains an active agent and the delivery vehicle. The pharmaceutical composition may be a topical, syringeable, or injectable formulation; and is suitable for local delivery of the active agent. Methods of treatment are also disclosed.

  半固态给药载体包含聚酯和赋形剂，半固态药物组合物包含活性剂和给药载体。该药物组合物可以是局部、注射或注射制剂；适用于活性剂的局部给药。还公开了治疗方法。